Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

AKRO holding history

Akero Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AKRO overviewAll 13F holders of AKROFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of AKRO by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−810,568−100.0%Sold outHolders
Q3 2025810,568$38.5M<0.1%+236,880+41.3%AddedHolders
Q2 2025573,688$30.6M<0.1%+47,046+8.9%AddedHolders
Q1 2025526,642$21.3M<0.1%+77,532+17.3%AddedHolders
Q4 2024449,110$12.5M<0.1%+442,014+6,229.1%AddedHolders
Q3 20247,096$203.6K<0.1%−11,066−60.9%ReducedHolders
Q2 202418,162$426.1K<0.1%−27,274−60.0%ReducedHolders
Q1 202445,436$1.15M<0.1%+24,493+117.0%AddedHolders
Q4 202320,943$489.0K<0.1%−81,477−79.6%ReducedHolders
Q3 2023102,420$5.18M<0.1%−166,497−61.9%ReducedHolders
Q2 2023268,917$12.6M<0.1%−14,599−5.1%ReducedHolders
Q1 2023283,516$10.8M<0.1%−7,090−2.4%ReducedHolders
Q4 2022290,606$15.9M<0.1%−785−0.3%ReducedHolders
Q3 2022291,391$9.92M<0.1%−70,597−19.5%ReducedHolders
Q2 2022361,988$3.42M<0.1%+24,198+7.2%AddedHolders
Q1 2022337,790$4.79M<0.1%+85,525+33.9%AddedHolders
Q4 2021252,265$5.34M<0.1%+42,019+20.0%AddedHolders
Q3 2021210,246$4.70M<0.1%−4,816−2.2%ReducedHolders
Q2 2021215,062$5.34M<0.1%+182,368+557.8%AddedHolders
Q1 202132,694$948.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.